Chemical Name: 6-(Cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide. Alternate Names: BMS-986165
Allosteric TYK2 inhibitor
Molecular Weight:
425.47
Purity:
98% by HPLC NMR (Conforms)
Form:
White or off-white solid
CAS Number:
[1609392-27-9]
Formula:
C20H19D3N8O3
Application Notes:
Deucravacitinib is very potent and selective allosteric inhibitor of tyrosine kinase 2 (TYK2). It binds to and is selective for the TYK2 pseudokinase domain (JH2, IC50 = 0.2 nM), with no activity against canonical JH1 domain of TYK2, JAK1,2, or 3.1 It is 5-fold less active against the JAK1 JH2 domain (IC50 = 1 nM). Deucravacitinib blocked signaling and functional responses in human TH17, TH1, B cells, and myeloid cells and displayed robust efficacy in vitro and in vivo in autoimmune disease animal models.2
* VAT and and shipping costs not included. Errors and price changes excepted